Cost-effective and accessible tests have a significant impact on public health. They enable mass screening programs, which are essential for identifying and isolating cases of infectious diseases. This, in turn, helps to reduce the spread of diseases and lowers the overall disease burden on the healthcare system. Additionally, these tests can improve patient outcomes by facilitating early treatment, which is often more effective and less costly than treatment at later stages of disease.
